Baldwin Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-4,437
Closed -$909K 112
2017
Q3
$909K Sell
4,437
-139
-3% -$32.3K 0.34% 45
2017
Q2
$1.11M Sell
4,576
-153
-3% -$36K 0.45% 32
2017
Q1
$1.13M Hold
4,729
0.44% 34
2016
Q4
$993K Sell
4,729
-1,106
-19% -$229K 0.39% 37
2016
Q3
$1.34M Sell
5,835
-151
-3% -$36.9K 0.57% 22
2016
Q2
$1.38M Buy
5,986
+567
+10% +$131K 0.59% 21
2016
Q1
$1.45M Buy
5,419
+52
+1% +$14.9K 0.63% 20
2015
Q4
$1.68M Buy
5,367
+926
+21% +$276K 0.75% 12
2015
Q3
$1.21M Buy
4,441
+423
+11% +$130K 0.53% 25
2015
Q2
$1.22M Buy
4,018
+205
+5% +$61.1K 0.5% 29
2015
Q1
$1.14M Buy
+3,813
New +$1.09M 0.45% 32

Other funds holding AGN

Baldwin Investment Management's AGN Position: Q4 2017 in Review

Baldwin Investment Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 4,437 shares — an estimated $909K sold.

Baldwin Investment Management first reported a position in AGN in Q1 2015 and held it in 11 quarters. The position peaked at $1.68M in Q4 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Baldwin Investment Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Baldwin Investment Management sold 4,437 Allergan plc shares in Q4 2017, an estimated $909K.
  • Baldwin Investment Management first reported a position in Allergan plc in Q1 2015 and held it in 11 quarters.
  • Baldwin Investment Management's Allergan plc position peaked at $1.68M in Q4 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Baldwin Investment Management's 13F filing for Q4 2017, filed 13 Feb 2018.